SG Americas Securities’s Pandion Therapeutics Inc. Common Stock PAND Stock Holding History

SG Americas Securities’s Portfolio PAND Stock Details PAND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-3,172	Closed	-$190K	–	3439
2021 Q1	$190K	Buy	+3,172	New	+$115K	﹤0.01%	2705

SG Americas Securities's PAND Position: Q2 2021 in Review

SG Americas Securities sold out of Pandion Therapeutics Inc. Common Stock (PAND) in Q2 2021, closing a stake of 3,172 shares — an estimated $190K sold.

SG Americas Securities first reported a position in PAND in Q1 2021 and held it in 1 quarter. The position peaked at $190K in Q1 2021. 0 funds tracked by Wall St. Rank hold PAND as of Q2 2021.

SG Americas Securities reported no remaining Pandion Therapeutics Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
SG Americas Securities sold 3,172 Pandion Therapeutics Inc. Common Stock shares in Q2 2021, an estimated $190K.
SG Americas Securities first reported a position in Pandion Therapeutics Inc. Common Stock in Q1 2021 and held it in 1 quarter.
SG Americas Securities's Pandion Therapeutics Inc. Common Stock position peaked at $190K in Q1 2021.
0 funds tracked by Wall St. Rank held Pandion Therapeutics Inc. Common Stock as of Q2 2021.

Based on SG Americas Securities's 13F filing for Q2 2021, filed 12 Aug 2021.